TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26571831

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 347

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 347
Study: 23508601

Group type: EXPERIMENTAL
Intervention: Intervention (point-of-care education, coaching, medication intensification)
Number of subjects: 727

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 727
Study: 21969080

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 25
Study: 18850104

Group type: EXPERIMENTAL
Intervention: Moisturizer 1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moisturizer 2
Number of subjects: 20
Study: 16736000

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (1.2 mg day(‐1) for 12 weeks)
Number of subjects: 61
Study: 15196414

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted sigmoid colpopoiesis
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoid colon colpopoiesis
Number of subjects: 9
Study: 11577960

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) using a bioabsorbable bilayer collagen membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (CTG)
Number of subjects: 20
Study: 10079865

Group type: EXPERIMENTAL
Intervention: Spiramycin
Number of subjects: 65

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 65
Study: 8273956

Group type: EXPERIMENTAL
Intervention: NMB-assisted oral intubation (succinylcholine 1.5 mg/kg IV)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Nasotracheal intubation (NTI)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: NMB-assisted oral intubation
Number of subjects: 77
Study: 3341821

Group type: EXPERIMENTAL
Intervention: Nissen operation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Belsey operation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Resection plus colon interposition
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Resection plus gastric interposition
Number of subjects: 50
Study: 30843497

Group type: EXPERIMENTAL
Intervention: Ma‐al‐Shaeer (MS) 15 g of dried MS powder twice daily for 14 days
Number of subjects: 77

Group type: COMPARATOR
Intervention: Fexofenadine (FX) 60 mg twice daily for 14 days
Number of subjects: 77
Study: 28720336

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF) metered dose inhaler (MDI) 18/9.6 μg
Number of subjects: 3699

Group type: COMPARATOR
Intervention: Monocomponent MDIs and placebo MDI
Number of subjects: 3699
Study: 25495272

Group type: EXPERIMENTAL
Intervention: Sequential therapy (5-day dual therapy with pantoprazole plus amoxicillin, followed by 5-day triple therapy with pantoprazole plus clarithromycin and metronidazole)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Reverse sequential therapy (5-day triple therapy with pantoprazole plus clarithromycin and metronidazole, followed by 5-day dual therapy with pantoprazole plus amoxicillin)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Reverse sequential therapy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 122
Study: 23841268

Group type: EXPERIMENTAL
Intervention: CMHSTBNA (Chinese medical herbs for Shen tonifying, blood nourishing and activating)
Number of subjects: 368
Study: 21740077

Group type: EXPERIMENTAL
Intervention: Low-dose pantoprazole (0.6 mg/kg equivalent)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose pantoprazole (1.2 mg/kg equivalent)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pantoprazole (both doses)
Number of subjects: 60
Study: 20144434

Group type: EXPERIMENTAL
Intervention: MedTone inhaler with TI powder
Number of subjects: 56
Study: 16706571

Group type: EXPERIMENTAL
Intervention: Reimbursement for smoking cessation treatment (SCT) for 6 months
Number of subjects: 1266

Group type: COMPARATOR
Intervention: No reimbursement (control group)
Number of subjects: 1266

Group type: EXPERIMENTAL
Intervention: Reimbursement for SCT
Number of subjects: 1266
Study: 15321933

Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 5 ng ml(‐1)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 10 ng ml(‐1)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Remifentanil target concentration of 15 ng ml(‐1)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cuff inflation with remifentanil
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Tracheal suctioning with remifentanil
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Tracheal suctioning
Number of subjects: 81
Study: 11763924

Group type: EXPERIMENTAL
Intervention: OptiBond (dual-cure glass filled adhesive) applied to 85 teeth
Number of subjects: 38

Group type: COMPARATOR
Intervention: Delton (self-cured sealant) applied to 86 teeth
Number of subjects: 38
Study: 9494176

Group type: EXPERIMENTAL
Intervention: Patch angioplasty
Number of subjects: 758
Study: 8336169

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 3109574

Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium heparin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous sodium heparin
Number of subjects: 100
Study: 29362250

Group type: EXPERIMENTAL
Intervention: Web-based sustainability programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal contact programme
Number of subjects: 0
Study: 27087212

Group type: EXPERIMENTAL
Intervention: Health management group
Number of subjects: 618

Group type: COMPARATOR
Intervention: General management group
Number of subjects: 618
Study: 23899896

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3899
Study: 22987210

Group type: EXPERIMENTAL
Intervention: 60-minute motivational/skills-building counseling session
Number of subjects: 307

Group type: COMPARATOR
Intervention: Written HIV prevention information material
Number of subjects: 307
Study: 19968833

Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bromocriptine 5 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bromocriptine 10 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bromocriptine (all doses)
Number of subjects: 60
Study: 18441691

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment adherence
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Reasons for missed drug intake
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Patient vs Physician interpretation of hypertension problems
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Barriers to regular drug intake
Number of subjects: 1298

Group type: EXPERIMENTAL
Intervention: Improvement strategies for compliance
Number of subjects: 1298
Study: 16784343

Group type: EXPERIMENTAL
Intervention: High epistemic motivation (EM) with cooperative tactics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High epistemic motivation (EM) with competitive tactics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low epistemic motivation (EM)
Number of subjects: 0
Study: 15213617

Group type: EXPERIMENTAL
Intervention: S
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: SRT
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: SCT
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 589
Study: 12184354

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group interventions
Number of subjects: 0
Study: 9546995

Group type: EXPERIMENTAL
Intervention: Device therapy in a blinded manner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical outcomes
Number of subjects: 0
Study: 8391856

Group type: EXPERIMENTAL
Intervention: N-9 once every other day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: N-9 once a day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: N-9 twice a day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: N-9 4 times a day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo 4 times a day
Number of subjects: 35
Study: 3085914

Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional TPN
Number of subjects: 10
Study: 30615139

Group type: EXPERIMENTAL
Intervention: Peer modeling risky behaviors
Number of subjects: 137

Group type: COMPARATOR
Intervention: Peer observation
Number of subjects: 137

Group type: COMPARATOR
Intervention: Safe modeling
Number of subjects: 137
Study: 28259499

Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10mg) for 8 weeks
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5‐25mg) for 8 weeks
Number of subjects: 88
Study: 25702618

Group type: EXPERIMENTAL
Intervention: 5mg/day rosuvastatin for 6 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 24080019

Group type: EXPERIMENTAL
Intervention: Ecstasy polydrug users
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonecstasy polydrug users
Number of subjects: 60

Group type: COMPARATOR
Intervention: Drug naive controls
Number of subjects: 60
Study: 21048776

Group type: EXPERIMENTAL
Intervention: Single width blood pressure cuff (12 cm)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Proportional width blood pressure cuff
Number of subjects: 101
Study: 19264929

Group type: EXPERIMENTAL
Intervention: Concept-Oriented Reading Instruction (CORI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Instruction (TI)
Number of subjects: 0
Study: 17685781

Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP) application for 3 to 5 seconds
Number of subjects: 40

Group type: COMPARATOR
Intervention: Self-etching primer (SEP) application for 15 seconds
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison of ARI scores between both groups
Number of subjects: 40
Study: 15339055

Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine combination (3-week schedule)
Number of subjects: 0
Study: 11334591

Group type: EXPERIMENTAL
Intervention: MEDLINE articles
Number of subjects: 6766

Group type: EXPERIMENTAL
Intervention: IME articles
Number of subjects: 6766

Group type: EXPERIMENTAL
Intervention: semFYC congress summaries
Number of subjects: 6766

Group type: COMPARATOR
Intervention: Review articles
Number of subjects: 6766
Study: 9215837

Group type: EXPERIMENTAL
Intervention: CVPP (3 cycles)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: CVPP (6 cycles)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: CVPP plus RT
Number of subjects: 256

Group type: COMPARATOR
Intervention: AOPE plus RT
Number of subjects: 256
Study: 8432481

Group type: EXPERIMENTAL
Intervention: Low dose cyclosporin (4.1 mg/kg/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 2835836

Group type: EXPERIMENTAL
Intervention: Topical antibiotic preparation (neomycin, bacitracin, and polymyxin B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 31251352

Group type: EXPERIMENTAL
Intervention: S. haematobium with hybrid ancestry from S. bovis
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: S. bovis-derived alleles
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Invadolysin gene family
Number of subjects: 96
Study: 28008749

Group type: EXPERIMENTAL
Intervention: INSIGHT responsive parenting intervention
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 291
Study: 25579833

Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health Programme (YAM)
Number of subjects: 11110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11110
Study: 24201233

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) up to 2 g/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 21632725

Group type: EXPERIMENTAL
Intervention: Family-to-Family Education Program (FTF)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (waitlisted participants)
Number of subjects: 318
Study: 19370425

Group type: EXPERIMENTAL
Intervention: Proton-beam therapy (PBT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 3D conformal X-ray therapy (3D-CRT)
Number of subjects: 24
Study: 16674614

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal oxygen insufflation at a flow of 5 l.min(‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no nasopharyngeal oxygen insufflation)
Number of subjects: 30
Study: 14571613

Group type: EXPERIMENTAL
Intervention: Kangxin capsule (KXC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Hydergine
Number of subjects: 63
Study: 11089449

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (40 mg, p.o.)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 4
Study: 8986480

Group type: EXPERIMENTAL
Intervention: Intratracheal oxygen insufflation (ITO2) via minitracheotomy (MT)
Number of subjects: 20
Study: 1456568

Group type: EXPERIMENTAL
Intervention: Nutritional therapy (controlled nutritional support)
Number of subjects: 0
Study: 3842839

Group type: EXPERIMENTAL
Intervention: Continuous stimulation at 60 db SPL for 7 min in the R ear during Phase II
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intermittent stimulation in the contralateral ear during Phase III
Number of subjects: 15

Group type: COMPARATOR
Intervention: Simultaneous, intermittent stimulation in both ears during Phase I
Number of subjects: 15
Study: 31337298

Group type: EXPERIMENTAL
Intervention: Endovascular treatment with successful reperfusion
Number of subjects: 2794

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase before endovascular treatment
Number of subjects: 2794

Group type: EXPERIMENTAL
Intervention: No interhospital transfer
Number of subjects: 2794

Group type: EXPERIMENTAL
Intervention: Lower stroke severity
Number of subjects: 2794

Group type: EXPERIMENTAL
Intervention: Smaller infarct size
Number of subjects: 2794

Group type: EXPERIMENTAL
Intervention: Reperfusion success
Number of subjects: 2794
Study: 30045101

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lateral approach for proximal sciatic nerve block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ultrasound-guided anterior approach for proximal sciatic nerve block
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cadaveric evaluation of the lateral approach
Number of subjects: 40
Study: 26603740

Group type: EXPERIMENTAL
Intervention: High volume aerobic exercise (300 minutes/week)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Moderate volume aerobic exercise (150 minutes/week)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Self-selected exercise level >246 minutes/week
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Self-selected exercise level <110 minutes/week
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Exercise time in target heart rate zone
Number of subjects: 400
Study: 24758079

Group type: EXPERIMENTAL
Intervention: Busheng Huoxue Capsule (BHC) plus caltrate-D (600 mg CaCO3)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Alendronate (70 mg per week) plus caltrate-D
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (BHC and Alendronate)
Number of subjects: 200
Study: 23106761

Group type: EXPERIMENTAL
Intervention: Modified Cognitive Processing Therapy (MCPT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stressor sessions
Number of subjects: 100
Study: 20124230

Group type: EXPERIMENTAL
Intervention: Extended therapy (Nicoderm CQ, 21 mg, for 24 weeks)
Number of subjects: 568
Study: 18406951

Group type: EXPERIMENTAL
Intervention: Partially restricted splint
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Highly restricted splint
Number of subjects: 42

Group type: COMPARATOR
Intervention: Baseline (no splint)
Number of subjects: 42
Study: 15935090

Group type: EXPERIMENTAL
Intervention: Homozygotes for the minor alleles of STAT3 polymorphisms
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: Repeated measures of FEV1 over 8 weeks
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: Haplotype analysis based on six polymorphisms
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: One polymorphism in childhood asthmatics
Number of subjects: 1053
Study: 12542901

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefepime (4-g continuous infusion over 24 h for 48 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intermittent injection of cefepime (2-g bolus every 12 h for 48 h)
Number of subjects: 10
Study: 10776311

Group type: EXPERIMENTAL
Intervention: Almarys Optima
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Almaris Quiet
Number of subjects: 0
Study: 8873689

Group type: EXPERIMENTAL
Intervention: Bumetanide (single intravenous bolus dose, doses ranged from 0.005 to 0.100 mg/kg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Bumetanide (single intravenous bolus dose)
Number of subjects: 53
Study: 1300059

Group type: EXPERIMENTAL
Intervention: Urapidil 12.5 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 6208312

Group type: EXPERIMENTAL
Intervention: Audiovisual presentations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pamphlets
Number of subjects: 0

Group type: COMPARATOR
Intervention: One-to-one dialogue
Number of subjects: 0
Study: 31539373

Group type: COMPARATOR
Intervention: Control vignette (typical woman)
Number of subjects: 1355

Group type: EXPERIMENTAL
Intervention: Vignette portraying untreated mental illness
Number of subjects: 1355

Group type: EXPERIMENTAL
Intervention: Vignette portraying effectively treated mental illness or treatment followed by subsequent relapse
Number of subjects: 1355
Study: 29653069

Group type: EXPERIMENTAL
Intervention: Breathing exercises (30 min/session, 7 times/week for 12 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study: 26716683

Group type: EXPERIMENTAL
Intervention: Ad containing a goal expectation violation manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control ad
Number of subjects: 0
Study: 24447043

Group type: COMPARATOR
Intervention: Brown Rice (BR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Brown Rice with Legumes (BRL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: White Rice (WR)
Number of subjects: 15
Study: 22415477

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg every 2 weeks or 15 mg/kg every 3 weeks) with chemotherapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Chemotherapy alone (placebo)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Bevacizumab with chemotherapy
Number of subjects: 159
Study: 20854598

Group type: EXPERIMENTAL
Intervention: Mandal‐type specialty school furniture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard school furniture
Number of subjects: 30
Study: 17926436

Group type: EXPERIMENTAL
Intervention: Behavioral graded activity (BGA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 200
Study: 16303936

Group type: EXPERIMENTAL
Intervention: linoleic acid (LA; 112 mg) and gamma‐linolenic acid (GLA; 15 mg) administered twice daily for 1 month
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo administered twice daily for 1 month
Number of subjects: 40
Study: 11575865

Group type: EXPERIMENTAL
Intervention: Nimodipine 60 mg four times daily (240 mg/d)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Nimodipine 30 mg four times daily (120 mg/d)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 85

Group type: COMPARATOR
Intervention: Stroke patients
Number of subjects: 85

Group type: COMPARATOR
Intervention: Stroke patients and control subjects pooled
Number of subjects: 85
Study: 9284774

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 343

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 343
Study: 8349366

Group type: EXPERIMENTAL
Intervention: Heparin exercise treatment (5000 IU intravenous dose, treadmill exercise 20 times for 2-3 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Medically treated patients (control group)
Number of subjects: 6
Study: 3329125

Group type: EXPERIMENTAL
Intervention: Metformin (M) 2550 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 10
Study: 2688804

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (20 Gy in four fractions)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 186
Study: 30293208

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (15 g prebiotics and 5 g probiotics containing Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium longum) for 12 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (5 g probiotics and 15 g maltodextrin) for 12 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (20 g maltodextrin) for 12 weeks
Number of subjects: 75
Study: 27487193

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate 18 mg (with potential increases up to 72 mg/d)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate
Number of subjects: 341
Study: 25617762

Group type: EXPERIMENTAL
Intervention: zopiclone 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: zopiclone 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: alcohol 50 g
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 23896972

Group type: EXPERIMENTAL
Intervention: Bone-marrow derived cell therapy (BMC) with a cell number above the median (324 × 10^6)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bone-marrow derived cell therapy (BMC) with a cell number below the median
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bone-marrow derived cell therapy (BMC) without microvascular obstruction (MO)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bone-marrow derived cell therapy (BMC)
Number of subjects: 42